How can we define and analyse drug exposure more precisely to improve the prediction of hospitalizations in longitudinal (claims) data?
Background: Risk prediction models can be powerful tools to support clinical decision-making, to help targeting interventions, and, thus, to improve clinical and economic outcomes, provided that model performance is good and sensitivity and specificity are well balanced. Drug utilization as a potent...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 73; no. 3; pp. 373 - 381 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Mar2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |